Accreditation Information

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 22.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Nurses Credentialing Center (ANCC) and the American Academy of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

The Royal College of Physicians and Surgeons of Canada recognizes live conferences or live courses held outside of Canada can be reported as accredited group learning activities under Section 1 of the MOC Program if they are developed by a university, academy, college, academic institution or physician organization.

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 22.50 hours of Category I credit for completing this program.

 

Needs Statement

This two-and-a-half day course will focus on the practical approach to electromyography in the diagnosis and management of neuromuscular disorders. Lectures will cover the clinical and neurophysiologic assessments of compression neuropathies, radiculopathies, plexopathies, various types of generalized neuropathies, neuromuscular junction disorders, myopathies, as well as the fundamentals of nerve conduction studies and needle electromyography and ultrasonographic evaluation of carpal tunnel syndrome and ulnar neuropathy. There will be live demonstrations to illustrate nerve conduction techniques and ultrasound evaluation of median and ulnar nerves. Emphasis will be placed on the latest treatment options for patients with various types of peripheral neuropathies.

Lecturers include four directors of Electromyography Laboratory/Neuropathy Center/ Neuromuscular Medicine/Neurology training programs, a Chair of Neurology, and other faculty from prestigious medical centers (Boston University, Columbia University, Harvard University, New York University, Oakland University, University of Massachusetts, and Wake Forest University).

A special two-hour session on the clinical uses of botulinum toxin in the treatment of spasticity, cervical dystonia, and other movement disorders will be presented. Participants will receive an update on the assessment and treatment of patients with neuromuscular disorders so that they may enhance their clinical practice.

Objectives

At the conclusion of this activity, participants will be able to:

  1. State the basic tenets of clinical and neurophysiologic diagnosis.
  2. List the clinical and neurophysiologic aspects of common neuromuscular disorders.
  3. Describe the technical aspects as well as potential pitfalls of nerve conduction studies and needle electromyography.
  4. Determine the current diagnostic and therapeutic approaches in polyneuropathy, including the use of intravenous immunoglobulins and plasma exchange.
  5. Discuss the use of ultrasound in the evaluation of patients with carpal tunnel syndrome and ulnar neuropathy.
  6. Discuss the clinical uses of botulinum toxin.
  7. Apply the knowledge reviewed above to the discussion of selected clinical cases.

Target Audience

Neurologists, physiatrists, neurosurgeons, orthopedic surgeons, internists, peripheral nerve surgeons, nurse practitioners, physician assistants, and electromyography technologists who are interested in the field of electromyography and neuromuscular disorders.

Faculty Disclosure

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.